Anna Ferrari MD
Professor, Medicine, New York University School of Medicine
Join to View Full Profile
195 Little Albany StNew Brunswick, NJ 08901
Phone+1 732-235-7687
Fax+1 732-235-8808
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 3 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Anna Ferrari, MD is an oncologist in New Brunswick, New Jersey. She is currently licensed to practice medicine in New Jersey and New York. She is a Professor at New York University School of Medicine.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1986 - 1987
Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1985 - 1986
MedStar Health Georgetown University (Baltimore)Residency, Internal Medicine, 1982 - 1985
Universidad de la República - Facultad de MedicinaClass of 1974
Certifications & Licensure
NY State Medical License 1985 - 2027
NJ State Medical License 2015 - 2019
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2012, 2014-2017
Publications & Presentations
PubMed
- 1 citationsMEK1/2 regulate normal BCR and ABL1 tumor-suppressor functions to dictate ATO response in TKI-resistant Ph+ leukemia.Laura Mazzera, Manuela Abeltino, Guerino Lombardi, Anna Maria Cantoni, Stefano Jottini
Leukemia. 2023-08-01 - 14 citationsTherapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemiaDaniele Caracciolo, Caterina Riillo, Andrea Ballerini, Giuseppe Gaipa, Ludovic Lhermitte
Journal for Immunotherapy of Cancer. 2021-02-01 - 6 citationsLoss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway.Antonella Padella, Maria Chiara Fontana, Giovanni Marconi, Eugenio Fonzi, Elisabetta Petracci
Blood Cancer Journal. 2021-01-07
Press Mentions
Madison Vaccines Incorporated Says Its Investigational New Prostate Cancer Treatment Is Available for the First Time in New Jersey Through a Clinical Trial at Rutgers Cancer Institute of New JerseyOctober 27th, 2016
